IFF and Kemira Form Joint Venture To Produce Sustainable Biobased Materials at Scale
NEW YORK – IFF (NYSE:IFF) and Kemira announced the formation of Alpha Bio, a joint venture aimed at commercial-scale production of renewable biobased materials. With an investment of approximately €130 million, the Alpha Bio facility will start production in late 2027, converting up to 44,000 MT of plant sugars to bioproducts, including high-performance biopolymers for use in various applications, such as home and personal care and industrial solutions. Alpha Bio’s production will use IFF’s Designed Enzymatic Biomaterial™ (DEB) platform technology, integrated at the IFF biorefinery in Kotka, Finland.
"Our partnership with Kemira has reached a significant milestone, enabling us to scale the production of groundbreaking biobased materials to meet the large and growing demand for high-performing and sustainable alternatives to fossil-derived polymers," said Erik Fyrwald, IFF CEO. "IFF’s DEB technology not only guarantees superior purity and consistency compared to traditional biopolymers but also enhances performance across various applications. This innovative approach allows us to combine biodegradability and material sustainability while maintaining cost efficiency and the high performance our customers expect."
IFF’s DEB platform leverages biotechnology by using plant-based sugars and enzymes under mild process conditions to create biobased materials, which can be tailored for specific product applications. This allows manufacturers to replace traditional fossil-based synthetic polymers with more sustainable alternatives. This highly efficient enzymatic polymerization process converts plant sugars to biopolymers, offering superior purity and consistency compared to conventional synthetic polymers. These tailored biopolymers enhance product performance across diverse applications.
“Since 2020, we’ve been collaborating with IFF using the DEB platform technology, which has allowed us to bring sustainable innovation to our key markets,” said Antti Salminen, CEO, Kemira Oyj. “The new joint venture will build on this initial success, enabling us to scale up production and provide new performance-competitive alternatives to fossil-based products in key markets, including paper and board packaging, paper coatings, and water treatment, while continuing to develop opportunities across other growth markets.”
Operating as an independent entity in Kotka, Finland, the joint venture will manufacture a specific line of products enabled by DEB technology for exclusive use by IFF and Kemira. The creation of Alpha Bio is expected to generate approximately 30 direct new jobs in the Kotka area with additional job creation during the project’s construction phase.
Categories
Countries
Companies
Latest news
Lyten to Acquire All Remaining Northvolt Assets in Sweden and Germany
Lyten, the global leader in lithium-sulfur batteries, announced today that it has entered into a binding agreement to acquire Northvolt’s remaining assets in Sweden and Germany.
Zero-Carbon Lithium: How Vulcan's Lionheart Project Is Revolutionizing Battery Production
Industriepark Höchst →The Vulcan Lionheart Project:with an integrated Geothermal and Lithium Extraction Plant in Landau and a Central Lithium Plant in the Höchst Industrial Park
Kemira to Invest in Tarragona Site to Expand Drinking Water Treatment Portfolio with New ACH Production Line
Chemmed Cluster Tarragona →The investment, of close to 20 million Euros, which was approved earlier this year will enable the construction of a new production line for Aluminium Chloro Hydrate (ACH), a high-performance coagu...
EIB and Eni sign €500 million finance agreement to convert Livorno refinery into a biorefinery
This will be Eni's third biorefinery in Italy, after those in Venice and Gela Among the distinctive features of the project, in addition to the use of advanced technologies, there is the possibilit...